Authors: Brada, M Hoang-Xuan, K Rampling, R Dietrich, PY Dirix, LY Macdonald, D Heimans, JJ Zonnenberg, BA Bravo-Marques, JM Henriksson, R Stupp, R Yue, N Bruner, J Dugan, M Rao, S Zaknoen, S

Citation: M. Brada et al., Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse, ANN ONCOL, 12(2), 2001, pp. 259-266

Authors: Rampling, R Cruickshank, G Papanastassiou, V Nicoll, J Hadley, D Brennan, D Petty, R MacLean, A Harland, J McKie, E Mabbs, R Brown, M

Citation: R. Rampling et al., Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma, GENE THER, 7(10), 2000, pp. 859-866

Authors: Fraser, G Rampling, R Smith, C Nicoll, J Stephen, M

Citation: G. Fraser et al., Long-term survival following extra-neural metastasis from a pineoblastoma, J NEURO-ONC, 48(2), 2000, pp. 141-144

Authors: Yung, WKA Albright, RE Olson, J Fredericks, R Fink, K Prados, MD Brada, M Spence, A Hohl, RJ Shapiro, W Glantz, M Greenberg, H Selker, RG Vick, NA Rampling, R Friedman, H Phillips, P Bruner, J Yue, N Osoba, D Zaknoen, S Levin, VA

Citation: Wka. Yung et al., A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse, BR J CANC, 83(5), 2000, pp. 588-593

Authors: Mairs, RJ Wideman, CL Angerson, WJ Whateley, TL Reza, MS Reeves, JR Robertson, LM Neshasteh-Riz, A Rampling, R Owens, J Allan, D Graham, DI

Citation: Rj. Mairs et al., Comparison of different methods of intracerebral administration of radioiododeoxyuridine for glioma therapy using a rat model, BR J CANC, 82(1), 2000, pp. 74-80